CollPlant Biotechnologies Ltd.
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Board
    • Partnering
  • Technology
    • rhCollagen
    • 3D Bioprinting
  • Product Pipeline
    • Collink.3D Bioinks
      • Collink.3D 50
      • Collink.3D 50L
      • Collink.3D 90
    • Gut-on-a-Chip
    • Medical Aesthetics
      • Dermal Fillers
      • Breast Implants
    • Vergenix products
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Media Room
    • Publications
    • Posters and Presentations
    • Media Coverage
    • Videos
  • Sustainability
  • Contact
    • Contact us
    • Careers
search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts
Nov 07, 2018 10:00am EST

CollPlant to Ring Nasdaq Opening Bell on November 8, 2018

Oct 28, 2018 8:00am EDT

CollPlant Shares Will Be Traded From Tuesday Oct 30 Exclusively on Nasdaq

Oct 22, 2018 4:00am EDT

CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

Sep 21, 2018 4:10pm EDT

CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug 28, 2018 7:00am EDT

CollPlant Holdings to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

Aug 08, 2018 9:00am EDT

Dual-Listed CollPlant to Voluntarily Delist From Tel Aviv Stock Exchange

Jul 05, 2018 5:55am EDT

CollPlant Appoints Dr. Wolfgang Ruttenstorfer to Its Board of Directors

Jun 26, 2018 5:55am EDT

CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs

Jun 19, 2018 7:55am EDT

CollPlant Appoints Professor Shay Soker from Wake Forest Institute for Regenerative Medicine to its Scientific Advisory Board

May 24, 2018 5:50am EDT

CollPlant Reports First Quarter 2018 Financial Results and Provides Business Update

RSS
  • Prev
    • 1...
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Details

    exploreCollPlant Ltd

    4 Oppenheimer Street
    P.O. Box 4132
    Rehovot 7670104, Israel

    LinkedinLinkedIn YoutubeYoutube TwitterTwitter
    local_phone+972 73 2325600
    local_printshop+972 73 2325602
    mailinfo@collplant.com

     
     

    ® 2025 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20